Review article
Role of the complement system in pulmonary disorders

https://doi.org/10.1016/S0162-3109(97)00058-1Get rights and content

Abstract

Immune injury in the lung is classically divided into types I-IV hypersensitivity, with the complement system being involved in types II and III hypersensitivity. Anaphylaxis and asthma are generally considered prototypes of type I hypersensitivity and hypersensitivity pneumonitis as an example of type III hypersensitivity in the lung. However, in asthma, for example, increasing evidence indicates that in addition to mast cells, T lymphocytes play an important role. Therefore, considering asthma as strictly a type I mediated reaction is too simplistic. This report will review the evidence regarding the involvement of the complement system and complement activation products in anaphylaxis, asthma and immune complex disease in various experimental models of pulmonary disease. Identification of the mediators responsible for the symptoms may suggest rational targets for the continued development of effective therapy to combat immune injury in the lung.

References (61)

  • M.L. Arndt et al.

    Soluble Complement Receptor 1 (sCR1) prevents the increase in C3a during systemic anaphylaxis in the guinea pig

    FASEB J.

    (1995)
  • C.M. Arroyave et al.

    Plasma complement changes during bronchospasm provoked in asthmatic patients

    Clin. Allergy

    (1977)
  • N. Berend et al.

    Indomethacin inhibits the increased airway responsiveness to histamine following inhalation of C5a des arg in rabbits

    Agents and Actions

    (1986)
  • B.S. Bochner et al.

    Immunological aspects of allergic asthma

    Annu. Rev. lmmunol.

    (1994)
  • G. Bodammer et al.

    Actions of anaphylatoxins on circulation and respiration of the guinea pig

    Int. Archs. Allergy Appl. Immun.

    (1967)
  • C.G. Cochrane et al.

    The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement

    J. Exp. Med.

    (1968)
  • P.J. Daffern et al.

    C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation

    J. Exp. Med.

    (1995)
  • U. del Balzo et al.

    Cardiac anaphylaxis-complement activation as an amplification system

    Circ. Res.

    (1989)
  • D.G. Fraser et al.

    Recombinant human C5a-induced bronchoconstriction in the guinea pig: inhibition by an H1 antagonist after depletion of circulating granulocytes and platelets

    J. Pharmacol. Exp. Ther.

    (1991)
  • D.G. Fraser et al.

    Trimellitic anhydride-induced allergic response in the lung: Role of the complement system in cellular changes

    J. Pharmacol. Exp. Ther.

    (1995)
  • E. Friedberger

    Weitere Untersuchungen uber Eiweissanaphylaxie. IV

    Z. ImmunForsch. Exp. Ther.

    (1910)
  • N.P. Gerard et al.

    Amino acid sequence of guinea pig C3a anaphylatoxin

    Protein Seq. Data Anal.

    (1988)
  • G.M. Halprin et al.

    Changes in arteriovenous complement activity induced by inhalation challenge

    Am. Rev. Respir. Dis.

    (1973)
  • J.P. Hayes et al.

    Specific immunological and bronchopulmonary responses following intradermal sensitization to free trimellitic anhydride in guinea pigs

    Clinical and Experimental Allergy

    (1991)
  • J.P. Hayes et al.

    Bronchial hyperreactivity after inhalation of trimellitic anhydride dust in guinea pigs after intradermal sensitization to free hapten

    Am. Rev. Respir. Dis.

    (1992)
  • J.P. Hayes et al.

    Involvement of inflammatory mediators in the airway responses to trimellitic anhydride in sensitized guinea-pigs

    Br. J. Pharmacol.

    (1992)
  • P.M. Henson et al.

    Acute immune complex disease in rabbits

  • S.P. Hogan et al.

    Cellular and molecular mechanisms involved in the regulation of eosinophil trafficking in vivo

    Medicinal Research Reviews

    (1996)
  • U.E. Höpken et al.

    The C5a chemoattractant receptor mediates mucosal defence to infection

    Nature

    (1996)
  • K.-H. Hsieh

    Changes of serum complement and eosinophil count in antigen induced bronchospasm

    Ann. Allergy

    (1978)
  • Cited by (21)

    • Complement

      2021, Encyclopedia of Respiratory Medicine, Second Edition
    • Anaphylatoxins coordinate innate and adaptive immune responses in allergic asthma

      2013, Seminars in Immunology
      Citation Excerpt :

      The role of the anaphylatoxins (AT) C3a and C5a as pro-inflammatory effector molecules of the complement system is well appreciated. As such, they have long been considered as drivers of bronchoconstriction and airway inflammation during the effector phase of allergic asthma [1]. More than a decade has passed since the first description that C5 can protect from the development of allergic asthma in a mouse model [2].

    • Immune complex disease (Serum Sickness)

      2007, xPharm: The Comprehensive Pharmacology Reference
    • COMPLEMENT

      2006, Encyclopedia of Respiratory Medicine: Volume 1-4
    • Complement

      2006, Encyclopedia of Respiratory Medicine, Four-Volume Set
    View all citing articles on Scopus

    Tel.: + 1-218-726-8950; fax: + 1-218-726-6235

    View full text